Literature DB >> 2845412

Targeting of an inducible toxic phenotype in animal cells.

E Borrelli1, R Heyman, M Hsi, R M Evans.   

Abstract

We have developed a toxic, or suicide, vector whose action is based on the targeted expression of the herpes simplex virus 1 thymidine kinase gene product in cultured cells or transgenic animals. This protein is able to convert nucleoside analogs such as acyclovir and 1-(2-deoxy-2-fluoro-beta-D-arabino-furanosyl)-5-iodouracil (FIAU) to toxic intermediates. The activation of these compounds disrupts cellular DNA replication, leading to rapid cell death. Neither acyclovir, FIAU, nor the herpes thymidine kinase alone is harmful to cells. This approach is simple and should have widespread applicability in studying lineage formation in cultured cells and transgenic animals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845412      PMCID: PMC282234          DOI: 10.1073/pnas.85.20.7572

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Transformation of mammalian cells by avian myelocytomatosis virus and avian erythroblastosis virus.

Authors:  K Quade
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

2.  Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.

Authors:  J A Fyfe; P M Keller; P A Furman; R L Miller; G B Elion
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

3.  B-lymphocyte targeting of gene expression in transgenic mice with the immunoglobulin heavy-chain enhancer.

Authors:  P Gerlinger; M LeMeur; C Irrmann; P Renard; C Wasylyk; B Wasylyk
Journal:  Nucleic Acids Res       Date:  1986-08-26       Impact factor: 16.971

4.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 7.  Transgenic mice: applications to the study of the nervous system.

Authors:  M G Rosenfeld; E B Crenshaw; S A Lira; L Swanson; E Borrelli; R Heyman; R M Evans
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

8.  1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.

Authors:  M M Mansuri; I Ghazzouli; M S Chen; H G Howell; P R Brodfuehrer; D A Benigni; J C Martin
Journal:  J Med Chem       Date:  1987-05       Impact factor: 7.446

9.  Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice.

Authors:  M L Breitman; S Clapoff; J Rossant; L C Tsui; L M Glode; I H Maxwell; A Bernstein
Journal:  Science       Date:  1987-12-11       Impact factor: 47.728

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  49 in total

1.  Ablation of a specific cell population by the replacement of a uniquely expressed gene with a toxin gene.

Authors:  K Arase; K Saijo; H Watanabe; A Konno; H Arase; T Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 2.  Imaging transgene expression with radionuclide imaging technologies.

Authors:  S S Gambhir; H R Herschman; S R Cherry; J R Barrio; N Satyamurthy; T Toyokuni; M E Phelps; S M Larson; J Balatoni; R Finn; M Sadelain; J Tjuvajev; R Blasberg
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

3.  Conditional ablation of T-cell development by a novel viral ion channel transgene.

Authors:  Claire A Smith; Christine M Graham; Kathleen Mathers; Anita Skinner; Alan J Hay; Cornelia Schroeder; D Brian Thomas
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

4.  A transgenic mouse model for inducible and reversible dysmyelination.

Authors:  C Mathis; C Hindelang; M LeMeur; E Borrelli
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

5.  Motor training compensates for cerebellar dysfunctions caused by oligodendrocyte ablation.

Authors:  Ludovic Collin; Alessandro Usiello; Eric Erbs; Carole Mathis; Emiliana Borrelli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

6.  Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries.

Authors:  R D Simari; H San; M Rekhter; T Ohno; D Gordon; G J Nabel; E G Nabel
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

7.  Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

Authors:  J Gaschet; A Lim; L Liem; R Vivien; M M Hallet; J L Harousseau; J Even; E Goulmy; M Bonneville; N Milpied; H Vié
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

8.  Identification, genome mapping, and CTCF binding of potential insulators within the FXYD5-COX7A1 locus of human chromosome 19q13.12.

Authors:  Sergey B Akopov; Vera M Ruda; Vera V Batrak; Anna S Vetchinova; Igor P Chernov; Lev G Nikolaev; Jürgen Bode; Eugene D Sverdlov
Journal:  Mamm Genome       Date:  2006-10-03       Impact factor: 2.957

9.  Targeted cell killing by reconstituted caspases.

Authors:  Dattananda S Chelur; Martin Chalfie
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

10.  Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

Authors:  D Barba; J Hardin; M Sadelain; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.